title: Ranolazine as a novel therapy for pulmonary arterial hypertension.
authors: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors: Mengqi
authors: M
authors: Gong
authors: Third Cardiology Department, Hippokrateion Hospital, Aristotle University Medical School, Thessaloniki, Greece.
authors: Nikolaos
authors: N
authors: Fragakis
authors: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors: Chengzong
authors: C
authors: Zhang
authors: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors: Zhiwei
authors: Z
authors: Zhang
authors: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors: Guangping
authors: G
authors: Li
authors: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China. Electronic address: liutongdoc@126.com.
authors: Tong
authors: T
authors: Liu
mesh_terms: D000818:Animals; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D000069458:Ranolazine / Q000494:pharmacology*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects*; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
chemical_list: D026941:Sodium Channel Blockers; D000069458:Ranolazine
keywords: Fatty acid oxidation; Late sodium current; Pulmonary arterial hypertension; Ranolazine